[HTML][HTML] Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
C Qin, S Yang, YH Chu, H Zhang, XW Pang… - Signal transduction and …, 2022 - nature.com
Ischemic stroke is caused primarily by an interruption in cerebral blood flow, which induces
severe neural injuries, and is one of the leading causes of death and disability worldwide …
severe neural injuries, and is one of the leading causes of death and disability worldwide …
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Ischemic stroke caused by arterial occlusion is the most common type of stroke, which is
among the most frequent causes of disability and death worldwide. Current treatment …
among the most frequent causes of disability and death worldwide. Current treatment …
[HTML][HTML] Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
AG Spiteri, CL Wishart, R Pamphlett, G Locatelli… - Acta …, 2022 - Springer
In neurological diseases, the actions of microglia, the resident myeloid cells of the CNS
parenchyma, may diverge from, or intersect with, those of recruited monocytes to drive …
parenchyma, may diverge from, or intersect with, those of recruited monocytes to drive …
Oxidative stress and regeneration
Regeneration is the process of replacing/restoring a damaged cell/tissue/organ to its full
function and is limited respecting complexity of specific organ structures and the level of …
function and is limited respecting complexity of specific organ structures and the level of …
[HTML][HTML] Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects
Z Tian, X Ji, J Liu - International Journal of Molecular Sciences, 2022 - mdpi.com
Vascular cognitive impairment and dementia (VCID) is a major heterogeneous brain
disease caused by multiple factors, and it is the second most common type of dementia in …
disease caused by multiple factors, and it is the second most common type of dementia in …
[HTML][HTML] Dental pulp stem cell-derived exosomes suppress M1 macrophage polarization through the ROS-MAPK-NFκB P65 signaling pathway after spinal cord injury
C Liu, F Hu, G Jiao, Y Guo, P Zhou, Y Zhang… - Journal of …, 2022 - Springer
Stem cell-derived exosomes have recently been regarded as potential drugs for treating
spinal cord injury (SCI) by reducing reactive oxygen species (ROS) and suppressing M1 …
spinal cord injury (SCI) by reducing reactive oxygen species (ROS) and suppressing M1 …
[HTML][HTML] The role of microglial phagocytosis in ischemic stroke
J Jia, L Yang, Y Chen, L Zheng, Y Chen, Y Xu… - Frontiers in …, 2022 - frontiersin.org
Microglia are the resident immune cells of the central nervous system that exert diverse roles
in the pathogenesis of ischemic stroke. During the past decades, microglial polarization and …
in the pathogenesis of ischemic stroke. During the past decades, microglial polarization and …
Predictive validity in drug discovery: what it is, why it matters and how to improve it
JW Scannell, J Bosley, JA Hickman… - Nature Reviews Drug …, 2022 - nature.com
Successful drug discovery is like finding oases of safety and efficacy in chemical and
biological deserts. Screens in disease models, and other decision tools used in drug …
biological deserts. Screens in disease models, and other decision tools used in drug …
[HTML][HTML] First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
M Hernández-Jiménez, S Martín-Vílchez… - … Therapy-Nucleic Acids, 2022 - cell.com
ApTOLL is an aptamer that antagonizes Toll-like receptor 4 and improves functional
outcomes in models of ischemic stroke and myocardial infarction. The aim of this study was …
outcomes in models of ischemic stroke and myocardial infarction. The aim of this study was …
[HTML][HTML] Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions
M Wilmes, C Pinto Espinoza, P Ludewig… - Journal of …, 2022 - Springer
Background Previous studies have demonstrated that purinergic receptors could be
therapeutic targets to modulate the inflammatory response in multiple models of brain …
therapeutic targets to modulate the inflammatory response in multiple models of brain …